Travoprost Implant for Glaucoma
Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Recruiting
Phase 3
Interventional Study
Glaucoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 510 (estimated)
- Sponsor
- Glaukos Corporation · Industry
Who this trial is looking for
This trial is looking for people with high pressure in the eye or open-angle glaucoma. Participants will evaluate the safety and effectiveness of a new implant used in the eye.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with ocular hypertension
- I have been diagnosed with open-angle glaucoma
You may not be able to join if
- I have had prior incisional glaucoma surgery in my study eye
- I have had prior argon laser trabeculoplasty in my study eye
- I have had prior minimally invasive glaucoma surgery in my study eye
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of Ocular Hypertension or Open-Angle Glaucoma in the study eye
Exclusion Criteria:
* Prior incisional glaucoma surgery in the study eye
* Prior argon laser trabeculoplasty (ALT) in the study eye
* Prior minimally invasive glaucoma (MIGS) surgery in the study eye
Contacts